Comprehensive Analysis of Potential Correlation Between Solute Carrier 1A (SLC1A) Family and Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common dangerous malignant tumor and the leading cause of global cancer incidence and mortality. The Solute Carrier 1A (SLC1A) family play a significant part in cellular biological process, inflammation, and immunity. Specific functions of the SLC1A family in l...

Full description

Saved in:
Bibliographic Details
Published in:International journal of general medicine 2022-01, Vol.15, p.2101-2117
Main Authors: Zhong, Xiaowu, Yao, Lihua, Xu, Lei, Ma, Qiang, Huang, Guangcheng, Yang, Miyuan, Gao, Chuanli, Cheng, Jibing, Zhou, Xi, Li, Qinrong, Guo, Xiaolan
Format: Article
Language:English
Subjects:
Adenocarcinoma
bioinformatics analysis
expression
Gene expression
Genes
Health aspects
lung adenocarcinoma
Lung cancer
Methylation
Mortality
Original Research
prognosis
slc1a family
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lung adenocarcinoma (LUAD) is the most common dangerous malignant tumor and the leading cause of global cancer incidence and mortality. The Solute Carrier 1A (SLC1A) family play a significant part in cellular biological process, inflammation, and immunity. Specific functions of the SLC1A family in lung cancer are still not systematically described. This study aimed to explore the best biological understanding of SLC1A family in lung cancer. To study the expression and role of the SLC1A family in lung cancer, researchers used a variety of bioinformatics databases and tools. Aberrant expression of SLC1A family genes were demonstrated and analyzed the association with gender, tumor grade, cancer stages, and nodal metastasis status. The ectopic expression of SLC1A family genes has prognostic value for LUAD patients. Immune infiltration revealed a significant correlation between SLC1A family genes expression in LUAD. SLC1A family genes were involved in manifold biological processes and have different levels of DNA methylation and genetic alteration. These findings suggested that members of the SLC1A family could be a potential target for the development of LUAD therapeutics as well as a reliable indicator of LUAD prognostic value.
ISSN:1178-7074
1178-7074
DOI:10.2147/IJGM.S350986